Back to Newsroom
    Company Announcements
    October 15, 2024
    3 min read
    Veracor Group

    Our Health System Partnership Model

    Veracor is pursuing partnerships that place signal-based medicine inside established provider networks. Here is how those arrangements are structured.

    Clinical team meeting inside a hospital corridor

    In short

    Veracor partners with existing provider organizations rather than building a parallel delivery system. Each arrangement starts as a pilot in a small number of facilities with agreed success criteria, protocols are integrated into existing clinician workflows, the health system remains custodian of patient data, and commercial terms expand only as pilot results justify it.

    Key takeaways

    • Pilot first: a defined patient population, a few facilities, agreed success criteria.
    • Protocols go inside existing clinician workflows rather than on top of them.
    • The health system stays custodian of patient data.
    • Veracor is in discussion with regional providers; no partner is named and no agreement is final.

    Signal-based medicine works best inside networks that already have patients, clinicians and referral pathways. Rather than building a parallel delivery system, Veracor is pursuing partnerships that place its monitoring and proactive-care protocols inside established provider organizations, with the Southeast United States as the initial focus.

    Why partner instead of building a provider network?

    Because the expensive parts already exist. A provider organization has licensed clinicians, patient relationships, referral patterns, credentialing, malpractice coverage and payer contracts. Recreating that to deliver a monitoring protocol would take years and would compete with the organizations best positioned to adopt the protocol. Partnering puts the capability where the patients are.

    How are these arrangements structured?

    Deliberately narrow at the start:

    • Pilot first. A defined patient population in a small number of facilities, with success criteria agreed in writing before any expansion is discussed.
    • Clinician-led. Protocols are integrated into existing workflows rather than layered on top of them. If a clinician has to open a second application, the protocol will not be used consistently.
    • Data held by the provider. The health system remains custodian of patient data, with access governed by the partnership agreement and applicable privacy law.
    • Staged commercial terms. Scope and economics expand only as pilot results justify it.
    • Defined exit. Both sides know in advance what ending the pilot looks like, including data handling on termination.

    What does a pilot actually test?

    Three things, in order. Whether the monitoring produces a signal clinicians consider actionable. Whether the alert reaches the right person inside their existing workflow and is acted on. Whether the resulting intervention changes anything measurable for the patient population. A pilot that only proves the technology functions has not tested the part that matters.

    What is the expected sequence?

    Where a partnership proceeds: a pilot phase, then an expansion phase informed by what the pilot showed, then broader network integration only after both. Timelines depend on the partner's own clinical governance, security review and contracting process, which commonly run six to twelve months before a pilot starts. Veracor plans for that rather than treating it as a delay.

    How is patient data protected?

    The provider organization remains the custodian of the record. Access by Veracor or a portfolio company is limited to what the agreement specifies for the pilot's stated purpose, under applicable privacy law and the partner's own security requirements. Security posture is treated as a gating item in these discussions, not a later cleanup task.

    What is the current status?

    Veracor is in discussion with regional provider organizations about arrangements of this type. No partner is being named, and no agreement should be assumed final until the firm announces it specifically. Discussions can end without a transaction.

    What makes a pilot fail?

    Rarely the technology. The recurring causes are a success criterion nobody agreed on in writing, an alert routed to a role with no authority to act, a clinical champion who leaves mid-pilot, and no identified budget owner for the expansion that was supposed to follow. Veracor tries to surface all four before a pilot starts, because each one is cheap to fix in a contract and expensive to fix in month five.

    What does the provider organization get out of it?

    Capability it would otherwise have to build: continuous visibility into a population between visits, a ranked view of which patients need clinical time this week, and the reporting infrastructure that risk-bearing contracts require. For a system already carrying outcome risk, those are direct financial interests rather than goodwill.

    How long does a partnership take to reach scale?

    Longer than most technology timelines assume. Clinical governance review, security assessment and contracting commonly run six to twelve months before a pilot begins, the pilot itself needs enough time for a measurable clinical signal, and expansion follows the partner's own budget cycle. A realistic path from first conversation to network-wide integration is measured in years. Veracor capitalizes for that rather than treating it as an obstacle to route around.

    How can a provider organization start a conversation?

    Through the contact form on this site. The most productive first conversations involve a specific patient population the organization already worries about, such as a group with high readmission rates or a panel too large for its available clinical time.

    Important note

    This article describes an intended partnership approach and is not medical, investment, legal or tax advice. Forward-looking statements about pilots, timelines and expansion are subject to change, and no agreement or outcome is promised.

    Company Announcements
    health system partnership model
    clinical pilot structure
    signal-based medicine integration
    provider network partnership
    Veracor Group

    744 words. Published October 15, 2024.

    Related Articles

    Veracor Outlines Kure Health Ecosystem Fund Strategy
    Company Announcements
    January 8, 2025

    Veracor Outlines Kure Health Ecosystem Fund Strategy

    The Kure Health Ecosystem Fund will pursue signal-based medicine, AI-assisted diagnostics and integrated care delivery, with a target capitalization of $100 million.

    Read More
    SMART Communities Initiative Announced
    Company Announcements
    November 20, 2024

    SMART Communities Initiative Announced

    A residential development model that places health, financial and technology services inside the community rather than across town.

    Read More
    VIBE Launches $100M Entrepreneurship Program
    Announcements
    December 15, 2024

    VIBE Launches $100M Entrepreneurship Program

    Veracor Investment in Business & Entrepreneurship sets a $100 million program target to back founders across the firm's four verticals.

    Read More
    Veracor Group

    Veteran-owned holding company operating across healthcare, real estate, finance, and technology. Opportunity Zone funds, the VIBE Fund, and Signal-Based Medicine.

    "Truth restores. Order heals."

    Veteran Owned Business

    Investment Disclosure: Our offerings under Regulation D 506(c) are available exclusively to accredited investors. Offerings under Regulation CF are available to non-accredited investors.

    For our current Regulation A offering, no sale may be made to you in this offering if the aggregate purchase price you pay is more than 10% of the greater of your annual income or net worth. Different rules apply to accredited investors and non-natural persons. Before making any representation that your investment does not exceed applicable thresholds, we encourage you to review Rule 251(d)(2)(i)(C) of Regulation A. For general information on investing, we encourage you to refer to www.investor.gov.

    For our anticipated Regulation A offering, until such time that the Offering Statement is qualified by the SEC, no money or consideration is being solicited, and if sent in response prior to qualification, such money will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified. Any offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date. A person's indication of interest involves no obligation or commitment of any kind.

    Entoro Securities Inc. is a registered broker-dealer. FINRA BrokerCheck
    Entoro Advisory LLC is a registered investment advisor.

    © 2026 Veracor Group LLC. All rights reserved.

    Cookie Preferences

    We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to our use of cookies. You can also choose "Essential Only" to accept only necessary cookies. Learn more about our cookie policy